Shilpa Medicare Limited's board of directors, at its meeting held on May 22, 2026, recommended a final dividend of ₹0.60 per equity share of face value ₹1 each for FY2026. The announcement was submitted to the NSE at 14:58 IST, hours after the board meeting outcome was disclosed. The dividend is subject to shareholder approval before it is formally declared and paid out.

Dividend Details and Yield

At the stock's last traded price of ₹499.45 on the day of the announcement, the declared dividend translates to a dividend yield of approximately 0.12%. The market capitalisation of the company stands at ₹9,769.31 Cr. The face value of each equity share is ₹1, making the ₹0.60 payout equivalent to a 60% dividend on face value.

Comparison to Previous Years

The FY2026 dividend of ₹0.60 per share represents a 45.5% decline compared to the ₹1.10 per share paid in both FY2022 and FY2021. The company had also paid ₹1.10 per share as an interim dividend in March 2020 and ₹1.00 per share for FY2019. Earlier payouts include ₹0.70 (interim, FY2018) and ₹0.60 per share for both FY2017 and FY2016. The current payout matches the levels last seen in FY2016 and FY2017, indicating a compression in dividend distribution relative to the ₹1.00 to ₹1.10 range that characterised the FY2019 to FY2022 period.

Dividend Trend Analysis

The trend reflects a peak dividend phase between FY2019 and FY2022, followed by a gap in payouts, and now a resumption at the lower end of the historical range. Notably, no dividend was recorded between FY2022 and FY2026, suggesting the company paused distributions for at least two to three financial years before resuming with this recommendation.

Valuation and Market Context

Shilpa Medicare is currently trading at a price-to-earnings (PE) ratio of 62.33, which is above the sector PE of 56.19, indicating the stock carries a valuation premium relative to its pharmaceutical sector peers. The stock hit a 52-week high of ₹515.50 on May 22, 2026, the same day as the dividend announcement, and trades significantly above its 52-week low of ₹259.50 recorded on January 27, 2026. The stock gained ₹24.80 or 5.22% on the day of the announcement, with the 52-week high coinciding with the board meeting outcome.

Trading Activity and Delivery Data

Volume on May 22 stood at 9,44,783 shares, with a delivery percentage of 48.75%. A delivery ratio approaching 50% on a high-volume day with a fresh 52-week high suggests meaningful participation from investors taking positional exposure rather than purely intraday activity. Daily volatility is recorded at 2.6%. The stock is a constituent of the Nifty Microcap 250, Nifty Total Market, and Nifty Smallcap 500 indices.

Company Background

Shilpa Medicare Limited, listed on the NSE under the symbol SHILPAMED with ISIN INE790G01023, is a Raichur-based pharmaceutical company engaged in active pharmaceutical ingredients and finished dosage formulations, with a focus on oncology products. The company operates across both domestic and international regulated markets.

Investors should note that the dividend remains a recommendation pending shareholder approval. The record date for dividend entitlement has not yet been announced by the company.